Express Pharma - Page 40 of 2223 - Express Pharma

India-US pharma ties look beyond generics

Dr Ashok Kumar Mittal elected to AIIMS Bathinda governing body

ACG appoints Lalit Kasliwal as Group Chief Financial Officer

Supriya Lifescience receives USFDA EIR with VAI classification for Lote Parshuram facility

Off label drug use and physician liability

Lupin launches Dapagliflozin and Metformin extended-release tablets in the United States

Zyax Chem acquires 26% stake in Gaymed Labs

OneSource and Orbicular secure USFDA tentative approval for generic semaglutide injection

India’s biopharma moment—If we get the ecosystem right

Morepen Laboratories clears fourth USFDA inspection at Masulkhana facility with NIL 483

Clinical exclusivity for indigenous medicines can improve long-term affordability and access

Rusan Pharma secures PMDA GMP approval for Ankleshwar and Dehradun facilities

Lupin subsidiary enters settlement agreement with Humana in US antitrust litigation